Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca Covid-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after India's drugs regulator approved Covishield for restricted emergency use.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3hJygNB
